KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹215 Cr | ₹212 Cr | ₹163 Cr | ₹127 Cr | ₹120 Cr |
What is the latest Sundry Debtors ratio of KOPRAN ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹215 Cr |
| Mar2024 | ₹212 Cr |
| Mar2023 | ₹163 Cr |
| Mar2022 | ₹127 Cr |
| Mar2021 | ₹120 Cr |
How is Sundry Debtors of KOPRAN Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹215 Cr | 1.23 | |
| Mar2024 | ₹212 Cr | 30.61 | |
| Mar2023 | ₹163 Cr | 27.64 | |
| Mar2022 | ₹127 Cr | 6.07 | |
| Mar2021 | ₹120 Cr | - | |
Compare Sundry Debtors of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹819.9 Cr | 2% | -5% | -43.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 2% |
-5% |
-43.9% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses